Call 1-877-744-5675 (Monday-Friday 8 AM-8 PM ET)

Making your patients’ support needs a priority. Together.

At Pfizer Oncology Together, we know how important it is that patients have access to their prescribed Pfizer Oncology treatment.

Pfizer Oncology Together is here to help patients navigate the access and reimbursement process and help patients identify financial assistance options.

    For patients who need support for their day-to-day challenges, we can connect them to resources and organizations that may provide assistance. Because when it comes to patient support, we’re in this together.

    Helping patients get support. Together.

    Forms & Resources

    Find forms to help patients access their prescribed Pfizer Oncology medications, including:

    •  Program enrollment 
    •  Product access 
    •  Sample letters and checklists 
    •  Billing and coding information 
    •  Co-pay assistance​​​​​​​

    Find Forms

    Co-pay Assistance

    Eligible, commercially insured patients may pay as little as $0 per month for oral medications or per treatment for certain injectable medications through our co-pay savings programs. Limits, terms, and conditions apply.*

    Check Eligibility

    FIND A LOCAL REIMBURSEMENT MANAGER

    Pfizer Oncology Field Reimbursement Managers (FRMs) are dedicated, specialized colleagues who offer personalized patient support services and provide localized patient support to healthcare providers for medications in the Pfizer Oncology portfolio.

    locate an frm

    *For oral products, click here and for injectable products, click here. Patients are not eligible for these programs if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. For oral products, patients may receive up to $10,000 per product in savings annually. For injectable products, maximum annual patient savings range from $10,000 to $25,000.

    Learn about product-specific resources. Together.

    Select a product to learn about the specific resources that come with each product.

    Select a product
    • ADCETRIS® (brentuximab vedotin)
    • AROMASIN® (exemestane)
    • BESPONSA® (inotuzumab ozogamicin)
    • BOSULIF® (bosutinib)
    • BRAFTOVI® (encorafenib)
    • DAURISMO™ (glasdegib)
    • ELREXFIO™ (elranatamab-bcmm)
    • IBRANCE® (palbociclib)
    • INLYTA® (axitinib)
    • LORBRENA® (lorlatinib)
    • MEKTOVI® (binimetinib)
    • MYLOTARG™ (gemtuzumab ozogamicin)
    • NIVESTYM® (filgrastim-aafi)
    • NYVEPRIA™ (pegfilgrastim-apgf)
    • RETACRIT® (epoetin alfa-epbx)
    • RUXIENCE® (rituximab-pvvr)
    • SUTENT® (sunitinib malate)
    • TALZENNA® (talazoparib)
    • TIVDAK® (tisotumab vedotin-tftv)
    • TRAZIMERA® (trastuzumab-qyyp)
    • TUKYSA® (tucatinib)
    • VIZIMPRO® (dacomitinib)
    • XALKORI® (crizotinib)
    • ZIRABEV® (bevacizumab-bvzr)
    FIND RESOURCES

    Please see full Prescribing Information for ADCETRIS, including BOXED WARNING and Medication Guide, or visit ADCETRISpro.com.

    Please see full Prescribing Information for BESPONSA, including BOXED WARNING, or visit BESPONSAhcp.com.

    Please see full Prescribing Information for CAMPTOSAR, including BOXED WARNING, or visit pfizer.com.

    Please see full Prescribing Information for DAURISMO, including BOXED WARNING and Medication Guide, or visit DAURISMOhcp.com.

    Please see full Prescribing Information for ELREXFIO, including BOXED WARNING and Medication Guide, or visit ELREXFIOhcp.com.

    Please see full Prescribing Information for MYLOTARG, including BOXED WARNING, or visit MYLOTARGhcp.com.

    Please see full Prescribing Information for RETACRIT, including BOXED WARNING and Medication Guide, or visit RETACRIThcp.com.

    Please see full Prescribing Information for RUXIENCE, including BOXED WARNING and Medication Guide, or visit RUXIENCEhcp.com.
    Pfizer Oncology Together supports patients prescribed RUXIENCE for oncology indications. Pfizer enCompass® is available to support patients prescribed RUXIENCE for its FDA-approved non-oncology indication. For more information, visit www.pfizerencompass.com.

    Please see full Prescribing Information for SUTENT, including BOXED WARNING and Medication Guide, or visit SUTENThcp.com.

    Please see full Prescribing Information for TIVDAK, including BOXED WARNING and Medication Guide, or visit TIVDAKhcp.com.

    Please see full Prescribing Information for TRAZIMERA, including BOXED WARNING, or visit TRAZIMERAhcp.com.

    Need assistance? Call 1-877-744-5675 (Mon–Fri 8 AM–8 PM ET)